Leading experts in nuclear medicine, radiopharmaceutical therapy, oncology and precision medicine from Africa and beyond are set to converge in Lagos for the 2026 International Symposium on Radiopharmaceutical Therapy (ISRT 2026).
The two-day symposium is scheduled for August 28 and 29, 2026, at Loveworld Medical Centre, Lagos, and is expected to provide a major platform for scientific exchange, professional education and collaboration on emerging approaches to cancer diagnosis and treatment.
The event will bring together specialists from Nigeria, South Africa, Algeria, Egypt, Kenya, Ethiopia, Germany, India and the United States, among other countries, reflecting its international scope.
The participating experts are drawn from fields including nuclear medicine, radiopharmaceutical therapy, theragnostics, molecular imaging, radiopharmacy, oncology and precision medicine.
Focus on New Cancer Treatment Technologies
ISRT 2026 will showcase developments in targeted radiopharmaceutical therapies, molecular imaging, radioligand therapy and other emerging approaches to precision cancer treatment.
The symposium is designed to examine how advances in these fields can improve the detection and treatment of cancer while supporting the development of more targeted and personalised approaches to patient care.
Beyond conventional scientific presentations, the programme will feature practical workshops, clinical case discussions and multidisciplinary learning sessions aimed at connecting scientific advances with real-world clinical practice.
Participants will also examine experiences from different African countries, providing an opportunity to discuss the opportunities and challenges involved in introducing advanced cancer-care technologies across diverse healthcare systems.
Building African Capacity
A central theme of the symposium is capacity building, with organisers placing emphasis on education, workforce development, international partnerships, technology transfer and long-term collaboration.
READ ALSO; Global specialists to explore future of cancer treatment at ISRT 2026
The organisers said the event would help connect African healthcare professionals with leading international experts while creating opportunities for knowledge sharing and professional development.
Discussions are also expected to focus on how radiopharmaceutical therapy and related technologies can be implemented sustainably across Africa, where access to advanced cancer diagnostics and treatment remains uneven.
Strengthening International Collaboration
The participation of experts from several continents is expected to provide an avenue for African specialists to exchange knowledge with international counterparts and explore potential areas of collaboration.
The symposium will particularly highlight the importance of multidisciplinary approaches to cancer care, bringing together professionals whose expertise spans diagnosis, imaging, drug development, treatment and patient management.
Such collaboration could help accelerate the adoption of emerging technologies while strengthening local expertise and healthcare infrastructure.
Loveworld Medical Centre Hosts Symposium
Hosted by Loveworld Medical Centre, the event forms part of the Loveworld Ministry of Healing, Health and Social Services’ broader commitment to advancing healthcare delivery and promoting access to medical knowledge and innovation in Africa.
The organisers said ISRT 2026 is intended not only as a scientific gathering but also as a platform for creating partnerships capable of translating advances in cancer medicine into sustainable healthcare solutions.
With its combination of international expertise, practical training, clinical discussions and strategic conversations on implementation, the symposium is expected to place African cancer care at the centre of discussions around the future of radiopharmaceutical therapy.
ISRT 2026 will hold on August 28–29 at Loveworld Medical Centre in Lagos under the theme of advancing theragnostics and transforming cancer care in Africa.